The acute assessment of MRgFUS therapies with metrics such as thermal dose and contrast-enhanced (CE) imaging have been shown to under- or over-estimate the final ablation lesion as assessed by delayed imaging or histological outcomes. The aim of this study is to longitudinally register MRgFUS treatment images to a final lesion outcome as determined by CE-T1w imaging three days post-treatment for voxel-wise analysis of these errors. MR thermometry (MRTI), cumulative thermal dose (CTD), and acute CE-T1w images are co-registered to Day 3 CE-T1w with millimeter accuracy and assessed for their predictive value.
This abstract and the presentation materials are available to members only; a login is required.